Grizzly Bulls LogoGrizzly BullsHow it WorksCalculator🚀 PremiumBlog
Log In

Grizzly Bulls’ Billionaires Index

⬅ # 57 Masayoshi Son|# 59 Low Tuck Kwong ➡

# 58 Dilip Shanghvi 

$29.5B

Real Time Net Worth
as of 12/19/2024
-$301.8M (-1.02%)

# 58 Dilip Shanghvi 

$29.5B

Real Time Net Worth
as of 12/19/2024
-$301.8M (-1.02%)
OccupationFounder, Sun Pharmaceuticals
Source of WealthPharmaceuticals
Age69
ResidenceMumbai, India
Marital StatusMarried
Children2
EducationBS, Calcutta University
Age-Adjusted Net Worth$16.0B
Dilip Shanghvi
Dilip Shanghvi
India
Net worth: $29.5B

Self-Made Score 

Breitling Superocean Heritage II Chronograph Automatic Blue Dial Men's Watch

Wealth History

Hover or tap to reveal net worth by year
Loading Chart

Biography

Overview

Dilip Shanghvi, born on October 1, 1955, is an Indian billionaire businessman and one of the country's richest individuals.
He hails from a Gujarati Hindu Vaishnav Kapol Vania family in Amreli, Gujarat.
Shanghvi earned a Bachelor of Commerce degree from the University of Calcutta and attended J. J. Ajmera High School and Bhawanipur Education Society College in Kolkata.
He is married to Vibha Shanghvi, and they have a son, Aalok, and a daughter, Vidhi, both of whom work for Sun Pharmaceuticals.
A devotee of Shrinathji, Shanghvi and his family make regular pilgrimages to the deity's abode in Nathdwara, Rajasthan.

Early Life

Shanghvi was born to Shantilal Shanghvi and Kumud Shanghvi in Amreli, Gujarat.
He spent his childhood and college life in the Burrabazar locality of Kolkata.
His initial education took place at J. J. Ajmera High School, and he later graduated from Bhawanipur Education Society College.

Career

Dilip Shanghvi borrowed $200 from his father in 1983 to start Sun Pharmaceutical Industries, focusing on psychiatric drugs.
He began in the pharmaceutical industry by assisting his father's wholesale dealership of medicines in Kolkata.
In 1982, at the age of 27, he established Sun Pharmaceutical Industries with a capital of INR 10,000, initially producing a single psychiatry drug.
Under Shanghvi's leadership, Sun Pharma expanded through acquisitions, including Caraco Pharma in 1997 and Taro Pharma in 2007.
In 2014, Sun Pharma acquired Ranbaxy Laboratories for $4 billion, becoming the largest drug company in India and the fifth-largest globally.
Shanghvi stepped down as chairman and CEO in 2012, and in May 2021, he resigned as Managing Director of SPARC, continuing as a non-executive director and chairman.

Community Involvement

In January 2018, Shanghvi was appointed to the Reserve Bank of India's 21-member central board committee.
He serves as the chairman of the board of governors at IIT Bombay.
Shanghvi became a trustee of the Rhodes scholarship programme at Oxford University in 2017.

Dilip Shanghvi's Wealth is Equivalent to:

22,702,079 Herman Miller Aeron Chairs

Herman Miller Aeron Chair

5,579,943 Gold Bars (50 gram)

24K Solid 50g Gold Ingot

301,395 Tiny Homes

Tiny House, Two Bedroom Solar Prefab Home

How long would it take you to become as rich as Dilip Shanghvi?

If you started with $10,000 and invested an additional $500 each month at a 42.79% CAGR, it would take you 5 years to reach Dilip Shanghvi's net worth of $29.5B.

Is this realistic? It depends how closely the VIX-TA-Macro Advanced model performs to its history in the future. Since Grizzly Bulls launched on January 1, 2022, it's returned 66.02% compared to 28.56% for the S&P 500 benchmark.

Enter data in all but one field below, then calculate the missing value

Dilip Shanghvi is very wealthy, but what's stopping you from reaching that same level of success? As summarized in our five fundamental rules to wealth building, becoming wealthy in a modern capitalist economy is not complicated. There's actually only three variables:

  1. Your starting capital
  2. Your earnings after expenses
  3. The compound annual growth rate (CAGR) of your savings

Most people start with zero or very little, so if you weren't born into wealth, don't fret! The majority of the fortunate folks listed in our Grizzly Bulls’ Billionaires Index came from middle class or lower backgrounds. The most distinguishing characteristic of the group is their ability to consistently earn a high CAGR on their savings.

Every billionaire has a unique strategy to achieve high CAGR. For Dilip Shanghvi, Pharmaceuticals is the primary source. Whether you choose to invest your savings in your own businesses or the businesses of others is not as important. The salient piece of the puzzle is ensuring that your hard-earned savings are generating sufficient CAGR to reach your long term goals.

Most people simply invest their money in index funds and call it a day. There's nothing wrong with this approach, but it guarantees relative mediocrity. To achieve greatness, you need to invest your money to earn higher than average returns. In the long run, better investors will always finish ahead of better earners.

Source: Grizzly Bulls reporting

Methodology: Grizzly Bulls' Billionaires Index is a daily ranking of the world's billionaires and richest people. Grizzly Bulls strives to provide the most accurate net worth calculations available. We pull data from public equity markets, SEC filings, public real estate records, and other reputable sources.

The index is dynamic and updates daily at the close of U.S. stock market trading based on changes in the markets, economy, and updates to Grizzly Bulls' proprietary algorithm of personal wealth calculation. Stakes in public companies are tracked daily based on the relevant closing prices of the underlying securities. Additionally, stakes in private companies, cash, real estate, and other less easily valued assets are updated periodically through careful analysis of insider transactions, comparable public company sales / EBITDA multiples, etc.

Affiliate Disclosure: Some of the links on this page are affiliate links. This means that, at no additional cost to you, we may earn a commission if you click through and make a purchase. We only recommend products or services we believe will add value to our readers.

Edited by: Lee Bailey